SUMMARY. We developed a binary gradient high-performance liquid chromatography (HPLC) method for measuring HbA 2 in whole blood samples using a Pharmacia Mono Q column (1 mL) and measurement at 415 nm. The assay requires a simple lysis and centrifugation step before injection onto the column. We found good agreement of results between the HPLC method and the Helena column chromatography method. The within batch precision was 2·6% and between batch precision was 4·6%. We found that using 30mM Tris buffers (pH 7,8) with a sodium chloride gradient resulted in short analysis times and good chromatographic separation of HbA 2 , HbS and HbA. We conclude that this is a robust assay for the diagnosis of p-thalassaemia.
A rapid anion exchange high-performance liquid chromatography method for the measurement of HbA 2 in whole blood SUMMARY. We developed a binary gradient high-performance liquid chromatography (HPLC) method for measuring HbA 2 in whole blood samples using a Pharmacia Mono Q column (1 mL) and measurement at 415 nm. The assay requires a simple lysis and centrifugation step before injection onto the column. We found good agreement of results between the HPLC method and the Helena column chromatography method. The within batch precision was 2·6% and between batch precision was 4·6%. We found that using 30mM Tris buffers (pH 7,8) with a sodium chloride gradient resulted in short analysis times and good chromatographic separation of HbA 2 , HbS and HbA. We conclude that this is a robust assay for the diagnosis of p-thalassaemia.
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Measurement of HbA 2 is used for the differential diagnosis of several anaemias and thalassaemias; increased HbA 2 is considered diagnostic of p-thalassaemia trait. The International Committee for Standardisation in Haematology recommends that HbA 2 be measured either by eluting haemoglobin bands from cellulose acetate following electrophoresis or by the use of anion exchange chromatography.' HbA 2 has also been measured by immunochemical techniques/ and laser densitometry. ' High-performance liquid chromatography (HPLC) methods are being increasingly used and a number of commercially available systems using ion exchange separation offer considerable savings in time.v? Many of these HPLC systems, however, use dedicated instruments with manufacturers' buffers and columns. The aim of this study was to investigate the possibility of using a commercially available anion exchange column, on a gradient HPLC system, to provide a quick alternative method for the analysis of HbA 2 .
METHODS
The HPLC equipment was supplied by Dyson Instruments UK Ltd (Tyne and Wear, UK)
Correspondence: Mr B G Keevil. and comprised two Shimadzu LClOAS pumps, one SPD IOAV UV/VIS spectrophotometric detector, one SIL lOA auto injector, one CTO lOA column oven and one CBM lOA communications module. Data reduction was done using Shimadzu Class LC lOA software which was run on an IBM compatible computer. The column was a Mono Q anion exchange column (1 mL), Pharmacia Biotech Ltd (St Albans, UK). The two eluting buffers were prepared as follows. Buffer A was 30 mmol/L Tris HCI with 0·2g/L sodium azide. Buffer B was buffer A incorporating 350 mmol/L sodium chloride. Both buffers were at pH7·8 (±0·05) and were degassed by vacuum filtration using a 0-45 jJ.m filter before use.
A 10 jJ.L sample of whole blood anticoagulated with ethylenediaminetetraacetic acid (EDTA) was mixed with 1 mL of physiological saline. After microcentrifugation at II 000 g for 3 min the supernatant was discarded. Red cells were lysed with 1·0 mL of a solution containing 10mmol/L potassium cyanide, Zmmol/L EDTA and 40 mmol/L Tris HCI (pH 8'0) added to the cell pellet and mixed well and cellular debris removed by microcentrifugation at II 000 g for 3 min.
A 5 jJ.L sample of the haemolysate was injected onto the column. The pump rate was 1·5 ml.jrnin and the salt gradient was as HbA 2 and HbA and in the shortest time possible. Using a buffer concentration of 30 mM and reducing the pH of both buffers to 7·8 allowed a steep salt gradient to be used and achieved a total run time of 7 min. Table I shows the precision of the method which was determined using samples from two patients with different concentrations of HbA 2 . The within assay precision was estimated during a single batch and the between assay precision was estimated in different batches over a one month period. At a concentration of 2·7% the within batch and between batch CV was 2·6 and 4·6%, respectively. The concentration of HbA 2 was expressed as the percentage of the total haemoglobin, determined at 415nm. The HPLC method achieved separation between HbA 2 and HbA. Figure I illustrates the separation of HbA2> HbA and HbS achievable with a sample to sample run time of 7 min. We could not achieve separation between all of the common Hb variants; both HbC and HbE were found to co-elute with HbA 2 and HbD was found to co-elute with HbS. Figure 2 illustrates the separation of HbC and HbA, with HbC superimposed on the HbA 2 peak. We also achieved some separation between HbA and HbF, but this would not be good enough to allow accurate quantification of small amounts of this variant.
Assay precision
The HbA 2 rich eluent from the Helena column, when analysed by HPLC, showed a single peak with the same retention time as that found in the blood samples.
The final pH and salt gradient conditions were optimized to give the best separation between Blood samples were collected into tubes containing dipotassium EDTA. Samples for the determination of a reference interval were taken from 187 patients with normal haematological indices. Samples were also taken from 86 patients in whom thalassaemia or haemoglobinopathy was suspected, for the method comparison. .sÑ E.
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.. We have extended the column life by injecting the minimum amount of protein onto the column and by regularly flushing and storing the column in water containing sodium azide. We have found the buffer pH critical in this assay and variations of 0·2 pH unit can have a significant effect on the chromatographic separation. It takes approximately 30 min to prepare a batch of 30 samples for analysis after which the procedure is fully automated. The total analysis time, including sample preparation for 30 samples, is 3·5 h. This is similar to the Helena column method but with much less direct operator involvement, which has resulted in considerable time saving, and has given us the added advantage of being able to separate HbS. We cannot identify HbA 2 in the presence of either HbC or HbE and this problem, which is also shared with the Helena column method, arises becase of the similarity in surface charge on these molecules. Amongst the 2000 patient samples analysed for HbA 2 over a 9 month period, approximately I % of these patients were found by electrophoresis to have HbC or HbE, and approximately 3% were found to have HbS or HbD. In the few samples that we have detected either HbC or HbE, the variant peak is usually much larger than the HbA 2 peak (> 10%) (Fig. 2) and has therefore caused few problems with interpretation. The method has Quantification of HbA 2 is a common request in our department for thalassaemia screening, and for this reason we investigated a fast HPLC method to replace the labour intensive BetaThai HbA 2 Quick Column kit from Helena Laboratories which was in use; we currently identify Hb variants by electrophoresis followed by HbA 2 analysis on selected samples. We report the optimization of the Pharmacia Mono Q column packed with a rigid monodisperse 15Jlm diameter bead anion exchange material, in an HPLC system. This column has been used in our department for the past 9 months and over Figure 3 shows a Bland-Altman plot,? for 86 patient results with good comparison between the HPLC method and the Helena p-Thai Quick Column 8 procedur e. A mean bias of 0·1% was found between the two methods and there was no systematic error over a wide concentration range. We found three outliers amongst the 86 data points «4%), which is less than the expected rate of 5% found in a Gaussian distribution. Differences within the 2 SD limits were not clinically important. Sample stability Whole blood samples were stable for at least 1 month when stored at 4°C but only for 2 days after treatment with the haemolysis reagent: not been optimized for the separation of all the common Hb variants but it is relatively easy to identify abnormal chromatograms that can then be confirmed by electrophoresis. In the patient samples that we have analysed, we have not missed a Hb variant that has previously been detected by electrophoresis, and the HbA 2 results from patients with fJ-thalassaemia have shown good separation from normal patients and thus confirmed the clinical usefulness of the assay.
Method comparison
We conclude that this is a quick and effective method for quantifying HbA 2 and provides an alternative to those laboratories with access to HPLC equipment wishing to automate the HbA 2 method. In addition, separation of HbS can be achieved and we are examining the possibility of quantifying this variant and also of using the method as a quick screening procedure prior to electrophoresis.
